|
You
are here: Home: BCU 2|2003: Faculty
Disclosures
Faculty Disclosures
The Postgraduate Institute for Medicine has a conflict of interest
policy that requires course faculty to disclose any real or apparent
commercial financial affiliations related to the content of their
presentations/materials. It is not assumed that these financial
interests or affiliations will have an adverse impact on faculty
presentations; they are simply noted in this supplement to fully
inform participants.
Michael Baum, ChM, FRCS
Grants/Research Support: AstraZeneca Pharmaceuticals,
LP
Consultant: Photo Electron Corp.
Peter Ravdin, MD, PhD
Consultant: Pharmacia
Speakers' Bureau: Pharmacia
Charles L Vogel, MD, FACP
Grants/Research Support; Consultant; Speakers' Bureau:
Genentech, Inc., SK Glaxo, Amgen,
Inc., Aventis Pharmaceuticals, Roche Laboratories, Inc., AstraZeneca
Pharmaceuticals,
LP Pharmacia, OrthoBiotech, Coley
Marc L Citron, MD
Speakers' Bureau: Novartis Pharmaceuticals
Neil Love, MD
Grants/Research Support: AstraZeneca Pharmaceuticals,
LP, Roche Laboratories, Inc.,
Genentech, Inc., Amgen, Inc., Cytyc Health Corporation, Sanofi-Synthelabo,
Inc.
This educational activity contains discussion of published and/or
investigational uses of agents that are not indicated by the FDA.
The Postgraduate Institute for Medicine and NL Communications, Inc.
do not recommend the use of any agent outside of the labeled indications.
Please refer to the official prescribing information for each product
for discussion of approved indications, contraindications and warnings.
The opinions expressed are those of the presenters and are not to
be construed as those of the publisher or grantor.
|
|
